Biotech Archives - Page 28 of 795

1 minute read

Morphic Therapeutic Announced The Presentation Of New Data Demonstrating Novel Real-Time Visualization Of Small Molecule α4β7 Inhibition Of Gut-Trafficking Cells

May 21, 8:11 AM

-α4β7 Inhibition Rapidly Increases the Rolling Velocity and Flux of B Cells in Gut-associated Lymphoid Tissues- -Impact of Potent and Selective Small Molecule Inhibitor Comparable to Monoclonal Antibody

MORF

1 minute read

Three Publications Demonstrate Bionano’s OGM’s Utility For Cell And Gene Therapy; Publications Include Niño Jesús University Children’s Hospital; Ruhr-University Bochum And Janssen

By Benzinga Newsdesk

May 21, 8:09 AM

Three peer-reviewed publications collectively illustrate the building support for optical genome mapping (OGM) as a tool for cell and gene therapy development that allows researchers in academic medical centers and

BNGO

2 minute read

AstraZeneca Targets Ambitious $80B In Total Revenue By 2030 Through Pipeline Expansion

By Vandana Singh

May 21, 7:16 AM

AstraZeneca aims to boost its revenue from $45.8 billion in 2023 to $80 billion by 2030. Key growth drivers include expanding oncology, biopharmaceuticals, rare disease portfolios, and launching 20 new medicines.

AZN

2 minute read

Why Is Dyne Therapeutics Stock Soaring On Monday?

By Vandana Singh

May 20, 3:53 PM

Dyne Therapeutics reported promising Phase 1/2 trial data for DYNE-101 in myotonic dystrophy type 1 and DYNE-251 in Duchenne muscular dystrophy. Improvements in splicing correction, myotonia, muscle strength, and dystrophin expression were observed.

DYN

1 minute read

Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population

By Vandana Singh

May 20, 2:38 PM

Amgen and AstraZeneca reveal Phase 2a results for Tezspire in severe COPD, showing a 17% reduction in exacerbations, with notable improvements in lung function and quality of life for patients with higher blood eosinophil counts.

AMGN

2 minute read

Esperion Therapeutics/Otsuka Partnered Cholesterol Drug Shows Effective In Japan Study

By Vandana Singh

May 20, 2:22 PM

Esperion Therapeutics and Otsuka Pharmaceutical report Phase 3 trial results for bempedoic acid in Japan, achieving significant LDL-C reduction in hypercholesterolemia patients. With no serious adverse events, a New Drug Application is planned for late 2024.

ESPR

2 minute read

Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute

By Vandana Singh

May 20, 2:18 PM

A Delaware jury ordered AstraZeneca to pay Pfizer $107.5 million, ruling that AstraZeneca's lung cancer drug Tagrisso infringed on Pfizer's patents related to cancer treatment.

AZN

2 minute read

European Commission Requests Reevaluation Of Opinion On PTC Therapeutics’ Duchenne Dystrophy Drug; Pauses Annual Guidance

By Vandana Singh

May 20, 12:03 PM

PTC Therapeutics announced that the European Commission has asked the CHMP to re-evaluate its negative opinion on the renewal of Translarna's conditional marketing authorization, keeping it available in Europe.

PTCT

2 minute read

Gilead’s Recently Acquired Liver Disease Candidate Shows Improvements In Disease Progression And Associated Itch

By Vandana Singh

May 20, 9:36 AM

Gilead Sciences reports interim results from the ASSURE study of seladelpar in primary biliary cholangitis, showing significant improvements in cholestasis markers and pruritus.

GILD

2 minute read

Genetic Profile Key To Novo Nordisk’s Wegovy’s Weight-Loss Effectiveness, Study Reveals

By Vandana Singh

May 20, 9:34 AM

Certain genes may predict strong responses to Novo Nordisk's Wegovy (semaglutide) in obesity treatment, with patients showing significant weight loss linked to a "hungry gut" genetic profile. This finding could enhance personalized obesity care, optimizing treatment outcomes.

NVO